Tower Research Capital LLC (TRC) - BIOTECH ACQUISITION COMPANY ownership

Back to all holdings Add to watchlist

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 68 filers reported holding BIOTECH ACQUISITION COMPANY in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q3 2022$8,0000.0%840
-1.2%
0.00%–
Q2 2022$8,000
-20.0%
850
-14.7%
0.00%–
Q1 2022$10,000
+400.0%
996
+410.8%
0.00%–
Q4 2021$2,000–195
+1525.0%
0.00%–
Q2 2021$0–120.0%0.00%–
Q1 2021$0–12–0.00%–
 Download
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q2 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BIOTECH ACQUISITION COMPANY shareholders